Survey of COVID-19 Research Provides Fresh Overview

Researchers at Karolinska Institutet in Sweden have explored all COVID-19 research published during the initial phase of the pandemic. The results, which were achieved by using a machine learning-based approach and published in the Journal of Medical Internet Research, will make it easier to direct future research to where it is most needed.

In the wake of the rapid spread of COVID-19, research on the disease has escalated dramatically. Over 60,000 COVID-19-related articles have been indexed to date in the medical database PubMed. This body of research is too large to be assessed by traditional methods, such as systematic and scoping reviews, which makes it difficult to gain a comprehensive overview of the science.

"Despite COVID-19 being a novel disease, several systematic reviews have already been published," says Andreas Älgå, medical doctor and researcher at the Department of Clinical Science and Education, Sodersjukhuset at Karolinska Institutet. "However, such reviews are extremely time- and resource-consuming, generally lag far behind the latest published evidence, and only focus on a specific aspect of the pandemic."

To obtain a fuller overview, Andreas Älgå and his colleagues have employed a machine learning technique that enables them to map key areas of a research field and track the development over time. This present study included 16,670 scientific papers on COVID-19 published from 14 February to 1 June 2020, divided into 14 different topics.

The study shows that the most common research topics were health care response, clinical manifestations, and psychosocial impact. Some topics, like health care response, declined over time, while others, such as clinical manifestations and protective measures, showed a growing trend of publications.

Protective measures, immunology, and clinical manifestations were the research topics published in journals with the highest average scientific ranking. The countries that accounted for the majority of publications (the USA, China, Italy and the UK) were also amongst the ones hardest hit by the pandemic.

"Our results indicate how the scientific community has reacted to the current pandemic, what issues were prioritised during the early phase and where in the world the research was conducted," says fellow-researcher Martin Nordberg, medical doctor and researcher at the Department of Clinical Science and Education, Sodersjukhuset.

The researchers have also developed a website, where regular updates on the evolution of the COVID-19 evidence base can be found.

"We hope that our results, including the website, could help researchers and policy makers to form a structured view of the research on COVID-19 and direct future research efforts accordingly," says Dr Älgå.

Andreas Älgå, Oskar Eriksson, Martin Nordberg.
Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study.
Journal of Medical Internet Research, 10 November 2020, doi: 10.2196/21559.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...